Medivation, Inc. (NASDAQ: MDVN) is a large market cap stock with a market cap of 10884.72. It is in the Biotechnology industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 30.98 and EPS of -1.17. At a stock price of 65.54 (-0.73%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 50.90%, more recently this last year it has grown by -11.10%. The next year growth is going to be about 66.88% and more long-term 37.15% after five years. EPS growth quarter over quarter is *TBA. Sales growth for the past five years have been 72.10% and sales growth quarter over quarter is 17.40%.
For performance, Medivation, Inc. the past week has seen a gain of 4.38%. For the last month performance for Medivation, Inc. is 6.93%. While the last quarter is 7.93% and half year, 116.89%. Finally for the year, performance is 34.53%.
The 52-week high for Medivation, Inc., is at -0.98%, and for the 52-week low it comes to a value of 148.16%. The 20-day simple moving average is 6.64% and 35.55% for the 200-day simple moving average.
Volatility for the week is at 1.83%, and for the month it is 1.66%. Medivation, Inc., has a target price of 67.
In terms of debt, long term debt/equity is 0, and for total debt/equity Medivation, Inc. has 0. The gross margin is *TBA, while operating margin is -26.30%, the profit margin is -17.20%. The current ratio is 4.3 and the quick ratio is 4.3.
Insider ownership is at 1.20%, with instituitional ownership at 90.10%. Medivation, Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 164.87. The shares float is 162.47, with the float short at 1.80%, with short ratio coming to 1.38.
In terms of returns, the return on assets see Medivation, Inc., get -13.00%, with its returns on investment at 27.10%. Return on equity is -23.80%. So will the investors see the target price of 67, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.